Fiduciary Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$647K Buy
2,547
+34
+1% +$7.92K 0.36% 26
2026
Q1
$614K Sell
2,513
-1,283
-34% -$299K 0.4% 24
2025
Q4
$786K Sell
3,796
-58
-2% -$11.5K 0.32% 30
2025
Q3
$715K Buy
3,854
+728
+23% +$125K 0.3% 30
2025
Q2
$478K Buy
3,126
+1,299
+71% +$200K 0.45% 27
2025
Q1
$303K Buy
+1,827
New +$286K 0.26% 25

Other funds holding JNJ

Fiduciary Wealth Partners's JNJ Position: Q2 2026 in Review

Fiduciary Wealth Partners increased its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, buying an estimated $7.92K and bringing the position to 2,547 shares worth $647K. The position accounts for 0.36% of the portfolio, ranked #26.

Fiduciary Wealth Partners first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. The position peaked at $786K in Q4 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Fiduciary Wealth Partners held 2,547 shares of Johnson & Johnson worth $647K as of Q2 2026.
  • Fiduciary Wealth Partners bought 34 Johnson & Johnson shares in Q2 2026, an estimated $7.92K.
  • Johnson & Johnson made up 0.36% of Fiduciary Wealth Partners's portfolio in Q2 2026, its #26 holding.
  • Fiduciary Wealth Partners first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • Fiduciary Wealth Partners's Johnson & Johnson position peaked at $786K in Q4 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fiduciary Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.